Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionHeadinvest, Llc
Latest Disclosed Ownership7,286 shares
Latest Disclosed Value $ 441,896
Headinvest, Llc reports 20.35% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 15, 2026 - Headinvest, Llc filed a 13F-HR form disclosing ownership of 7,286 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $381,932 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 9,148 shares of Bristol-Myers Squibb Company. This represents a change in shares of -20.35% during the quarter. The current value of the position is $345,575 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 7,286 -1,862 -20.35 442 -10.18 0.0906
2026-02-02 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 9,148 -2,306 -20.13 491 -5.03 0.0977
2025-11-14 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 11,454 -875 -7.10 517 -9.30 0.1069
2025-08-14 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,329 -690 -5.30 571 -28.21 0.1216
2025-05-15 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,019 -3,027 -18.86 794 -12.46 0.1544
2025-02-18 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,046 -2,301 -12.54 908 -4.43 0.1713
2024-11-15 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 18,347 -1,096 -5.64 949 17.60 0.1757
2024-08-14 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 19,443 1,072 5.84 807 -18.98 0.1590
2024-08-14 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 18,371 2,019 12.35 996 18.71 0.1944
2024-02-12 2023-12-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 16,352 -1,711 -9.47 839 -19.64 0.1745
2023-12-11 2023-09-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 18,063 -1,080 -5.64 1,045 -10.92 0.2270
2023-08-23 2023-06-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 19,143 -9,787 -33.83 1,172 -41.55 0.2526
2023-05-17 2023-03-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 28,930 -1,725 -5.63 2,005 -9.07 0.4398
2023-02-13 2022-12-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 30,655 2,654 9.48 2,206 10.75 0.4936
2022-12-28 2022-09-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 28,001 -50 -0.18 1,991 -7.82 0.4770
2022-08-12 2022-06-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 28,051 355 1.28 2,160 6.77 0.4807
2022-05-13 2022-03-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 27,696 893 3.33 2,023 21.07 0.3866
2022-02-11 2021-12-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 26,803 -240 -0.89 1,671 4.44 0.2964
2021-11-16 2021-09-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 27,043 920 3.52 1,600 -8.31 0.3034
2021-08-30 2021-06-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 26,123 1,667 6.82 1,745 13.09 0.3319
2021-05-13 2021-03-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 24,456 110 0.45 1,543 2.19 0.3149
2021-02-16 2020-12-31 13F/A-1 Bristol-Myers Squibb COM 110122108 24,346 2,670 12.32 1,510 15.53 0.3205
2021-02-16 2020-12-31 13F Bristol-Myers Squibb COM 110122108 21,676 1,307 0.3777
2020-11-24 2020-09-30 13F Bristol-Myers Squibb COM 110122108 21,676 1,812 9.12 1,307 11.90 0.3777
2020-08-12 2020-06-30 13F Bristol-Myers Squibb COM 110122108 19,864 2,317 13.20 1,168 19.43 0.3680
2020-05-12 2020-03-31 13F/A-1 Bristol-Myers Squibb COM 110122108 17,547 5,582 46.65 978 27.34 0.3661
2020-05-11 2020-03-31 13F Bristol-Myers Squibb COM 110122108 12,250 285 584 163,627.6015
2020-02-14 2019-12-31 13F Bristol-Myers Squibb COM 110122108 11,965 7,715 181.53 768 255.56 0.2205
2019-11-21 2019-09-30 13F Bristol-Myers Squibb COM 110122108 4,250 -8,000 -65.31 216 -61.15 0.0655
2019-08-22 2019-06-30 13F Bristol-Myers Squibb COM 110122108 12,250 0 0.00 556 -4.79 0.1573
2019-05-15 2019-03-31 13F Bristol-Myers Squibb COM 110122108 12,250 -12,250 -50.00 584 -54.16 0.1636
2019-02-22 2018-12-31 13F Bristol-Myers Squibb COM 110122108 24,500 11,850 93.68 1,274 62.29 0.2018
2018-11-14 2018-09-30 13F Bristol-Myers Squibb COM 110122108 12,650 -77 -0.61 785 11.51 0.2259
2018-08-09 2018-06-30 13F Bristol-Myers Squibb COM 110122108 12,727 -48 -0.38 704 -12.87 0.2146
2018-04-09 2018-03-31 13F Bristol-Myers Squibb COM 110122108 12,775 0 0.00 808 3.19 0.2591
2018-01-30 2017-12-31 13F Bristol-Myers Squibb COM 110122108 12,775 0 0.00 783 -0.63 0.2415
2017-11-13 2017-09-30 13F Bristol-Myers Squibb COM 110122108 12,775 100 0.79 788 11.61 0.2468
2017-07-18 2017-06-30 13F Bristol-Myers Squibb COM 110122108 12,675 0 0.00 706 2.47 0.2326
2017-04-25 2017-03-31 13F Bristol-Myers Squibb COM 110122108 12,675 2,375 23.06 689 14.45 0.2315
2017-01-24 2016-12-31 13F Bristol-Myers Squibb COM 110122108 10,300 700 7.29 602 25.94 0.2239
2016-10-11 2016-09-30 13F Bristol-Myers Squibb COM 110122108 9,600 -2,600 -21.31 478 -46.71 0.1695
2016-07-26 2016-06-30 13F Bristol-Myers Squibb COM 110122108 12,200 -200 -1.61 897 13.26 0.3394
2016-04-21 2016-03-31 13F Bristol-Myers Squibb COM 110122108 12,400 -267 -2.11 792 -9.07 0.3100
2016-01-20 2015-12-31 13F Bristol-Myers Squibb COM 110122108 12,667 0 0.00 871 16.13 0.3530
2015-10-16 2015-09-30 13F Bristol-Myers Squibb COM 110122108 12,667 -855 -6.32 750 -16.67 0.3011
2015-08-07 2015-06-30 13F Bristol-Myers Squibb COM 110122108 13,522 0 0.00 900 3.21 0.3332
2015-05-14 2015-03-31 13F Bristol-Myers Squibb COM 110122108 13,522 200 1.50 872 10.94 0.3129
2015-02-10 2014-12-31 13F Bristol-Myers Squibb COM 110122108 13,322 0 0.00 786 1.42 0.3134
2014-11-12 2014-09-30 13F Bristol-Myers Squibb COM 110122108 13,322 0 0.00 775 19.97 0.3098
2014-07-31 2014-06-30 13F Bristol-Myers Squibb COM 110122108 13,322 0 0.00 646 -6.65 0.2613
2014-05-07 2014-03-31 13F Bristol-Myers Squibb COM 110122108 13,322 -100 -0.75 692 -2.95 0.2979
2014-02-12 2013-12-31 13F Bristol-Myers Squibb COM 110122108 13,422 0 0.00 713 14.81 0.3005
2013-11-15 2013-09-30 13F Bristol-Myers Squibb COM 110122108 13,422 -132 -0.97 621 2.48 0.2708
2013-07-30 2013-06-30 13F Bristol-Myers Squibb COM 110122108 13,554 13,554 606 0.2666
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.